Antidepressant Response in Major Depressive Disorder: A Meta-Regression Comparison of Randomized Controlled Trials and Observational Studies

被引:50
作者
Naudet, Florian [1 ,2 ,3 ]
Maria, Anne Solene [1 ,4 ]
Falissard, Bruno [1 ,5 ,6 ,7 ]
机构
[1] Inst Natl Sante & Rech Med, U669, Paris, France
[2] Univ Rennes 1, Unite Rech Univ Behav & Basal Ganglia EM 425, Rennes, France
[3] Univ Psychiatrie, Serv Hosp, Ctr Hosp Guillaume Regnier, Rennes, France
[4] Ecole Psychol Praticiens, Paris, France
[5] Univ Paris Sud, Paris, France
[6] Univ Paris 05, Unite Mixte Rech S0669, Paris, France
[7] Hop Paul Brousse, Assistance Publ Hop Paris, Dept Sante Publ, Villejuif, France
来源
PLOS ONE | 2011年 / 6卷 / 06期
关键词
PLACEBO-RESPONSE; EFFICACY TRIALS; PRIMARY-CARE; DOUBLE-BLIND; METAANALYSIS; COEFFICIENTS; SEVERITY; BENEFITS; CRITERIA;
D O I
10.1371/journal.pone.0020811
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: To compare response to antidepressants between randomized controlled trials (RCTs) and observational trials. Methods and Findings: Published and unpublished studies (from 1989 to 2009) were searched for by 2 reviewers on Medline, the Cochrane library, Embase, clinicaltrials. gov, Current Controlled Trial, bibliographies and by mailing key organisations and researchers. RCTs and observational studies on fluoxetine or venlafaxine in first-line treatment for major depressive disorder reported in English, French or Spanish language were included in the main analysis. Studies including patients from a wider spectrum of depressive disorders (anxious depression, minor depressive episode, dysthymia) were added in a second analysis. The main outcome was the pre-/post-treatment difference on depression scales standardised to 100 (17-item or 21-item Hamilton Rating Scale for Depression or Montgomery and Asberg Rating Scale) in each study arm. A meta-regression was conducted to adjust the comparison between observational studies and RCTs on treatment type, study characteristics and average patient characteristics. 12 observational studies and 109 RCTs involving 6757 and 11035 patients in 12 and 149 arms were included in the main analysis. Meta-regression showed that the standardised treatment response in RCTs is greater by a magnitude of 4.59 (2.61 to 6.56). Study characteristics were related to standardised treatment response, positively (study duration, number of follow-up assessments, outpatients versus inpatients, per protocol analysis versus intention to treat analysis) or negatively (blinded design, placebo design). At patient level, response increased with baseline severity and decreased with age. Results of the second analysis were consistent with this. Conclusions: Response to antidepressants is greater in RCTs than in observational studies. Observational studies should be considered as a necessary complement to RCTs.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Efficacy, safety and mechanistic insights of pentoxifylline in major depressive disorder: a systematic review and meta-analysis of randomized controlled trials
    Kassar, Omar
    Farag, Nourallah
    Selim, Abdullah
    Taman, Lamees
    Alaa, Menna
    Elshahat, Ahmed
    Abouelmagd, Moaz Elsayed
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
  • [22] Brivaracetam Add-on Therapy for Epilepsy: Evidence Based Meta-analysis and Meta-regression of Randomized Controlled Trials
    Dasari, Anil
    Bansal, Dipika
    Gudala, Kapil
    JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, 2017, 34 (01): : 1 - 15
  • [23] Cariprazine specificity profile in the treatment of acute schizophrenia: a meta-analysis and meta-regression of randomized-controlled trials
    Corponi, Filippo
    Serretti, Alessandro
    Montgomery, Stuart
    Fabbri, Chiara
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2017, 32 (06) : 309 - 318
  • [24] Effectiveness of TES and rTMS for the Treatment of Insomnia: Meta-Analysis and Meta-Regression of Randomized Sham-Controlled Trials
    Ma, Haixia
    Lin, Jingxia
    He, Jiali
    Lo, Dilys Hoi Ting
    Tsang, Hector W. H.
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [25] Antioxidant uric acid in treated and untreated subjects with major depressive disorder: a meta-analysis and meta-regression
    Francesco Bartoli
    Giulia Trotta
    Cristina Crocamo
    Maria Rosaria Malerba
    Massimo Clerici
    Giuseppe Carrà
    European Archives of Psychiatry and Clinical Neuroscience, 2018, 268 : 119 - 127
  • [26] The prevalence of painful physical symptoms in major depressive disorder: A systematic review and meta-analysis of observational studies
    Liu, Zi-Han
    Jin, Yu
    Rao, Wen-Wang
    Zhang, Qinge
    Zhang, Juan
    Jackson, Todd
    Su, Zhaohui
    Xiang, Yu-Tao
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 111
  • [27] Impact of placebo arms on outcomes in antidepressant trials: systematic review and meta-regression analysis
    Salanti, Georgia
    Chaimani, Anna
    Furukawa, Toshi A.
    Higgins, Julian P. T.
    Ogawa, Yusuke
    Cipriani, Andrea
    Egger, Matthias
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2018, 47 (05) : 1454 - 1464
  • [28] Antioxidant uric acid in treated and untreated subjects with major depressive disorder: a meta-analysis and meta-regression
    Bartoli, Francesco
    Trotta, Giulia
    Crocamo, Cristina
    Malerba, Maria Rosaria
    Clerici, Massimo
    Carra, Giuseppe
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2018, 268 (02) : 119 - 127
  • [29] Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials
    Nelson, J. Craig
    Papakostas, George I.
    AMERICAN JOURNAL OF PSYCHIATRY, 2009, 166 (09) : 980 - 991
  • [30] Mindfulness-based interventions for major depressive disorder: A comprehensive meta-analysis of randomized controlled trials
    Wang, Yuan-Yuan
    Li, Xiao-Hong
    Zheng, Wei
    Xu, Zi-Yan
    Ng, Chee H.
    Ungvari, Gabor S.
    Yuan, Zhen
    Xiang, Yu-Tao
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 229 : 429 - 436